Stockreport

Plus Therapeutics Shareholder Update: Transition Achieved in 2019; Poised for Expansion in 2020

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today issued the following Letter to Shareholders from Dr. Marc [Read more]